Get started

XBI

Opening (IRA): XBI May 16th -91C/October 17th 60C LCD*... for a 26.56 debit. Comments: Back in to XBI on weakness, buying the back month 90 delta and selling the front month that pays for all of the extrinsic in the long. (The back month 60C is shown at the 80 so that it fits on the chart). Metrics: Buying Power Effect: 26.56 Break Even: 86.56 Max Profit: 4.44 ROC at Max: 16.72% 50% Max: 2.22 ROC at 50% Max: 8.36% Will generally look to take profit on the setup as a unit at 50% max, roll out the short call at 50% max to reduce my downside break even. * -- Long call diagonal.
AMEX:XBILong
by NaughtyPines
Opening (IRA): XBI May 16th -85C/December 19th 50C LCD*... for a 29.50 debit. Comments: Adding to my XBI position at or near 52-week lows, buying the back month 90 delta and selling the front month -30 delta that pays for all of the extrinsic in the long. (The 50C is depicted at a higher strike so that it fits on the chart). Metrics: Buying Power Effect: 29.50 Max Profit: 5.50 ROC at Max: 18.64% 50% Max: 2.25 ROC at 50% Max: 9.37% Will generally look to take profit at 50% max and/or roll out short call to reduce downside break even. * -- Long call diagonal.
AMEX:XBILong
by NaughtyPines
Opening (IRA): XBI Sept 19th 60C/April 17th -90C LCD*... for a 26.68 debit. Comments: Taking a bullish assumption directional shot near 52 week lows, buying the 90 delta back month and selling a front month that pays for all the extrinsic in the long, resulting in a break even that is at or below where the underlying is currently trading. The 60 long call is shown at 80 so that it fits on the chart ... . Metrics: Buying Power Effect: 26.68 Break Even: 86.88 Max Profit: 3.32 ROC at Max: 12.44% 50% Max: 1.66 ROC at 50% Max: 6.22% Delta/Theta: 53.79/3.51 Will generally look to take profit on the setup as a unit at 50% max and/or roll out the short call at 50% max to reduce cost basis/downside break even. * -- Long Call Diagonal
AMEX:XBILong
by NaughtyPines
Opening (IRA): XBI March 21st 85 Covered Call... for an 83.52 debit. Comments: One of the only red things on my ETF board ... . Selling the -75 delta call against shares to emulate the delta metrics of a 25 delta short put, but with the built-in defense of the short call. Just trying to squeeze in a little more into March while the monthly options contract is in that 35 to 56 DTE window. The ROC %-age isn't what I like to see out of these (2.0% or greater), but, hey, you can't have everything ... . Metrics: Buying Power Effect/Break Even: 83.52 Max Profit: 1.48 ROC at Max: 1.77% 50% Max: .74 ROC at 50% Max: .89%
AMEX:XBILong
by NaughtyPines
$XBI Starting New Bullish Trend?AMEX:XBI has been range bound (wide range) for a year. Recently it has been in a downtrend as defined by lower highs and lower lows. However, it looks like we now have a recent higher high and (maybe) a higher low. There are still technical challenges like it is under all moving averages. It would look much better once it gets above the shorter-term MAs which are all declining. The MACD is on a slight downward slope as well. Having pointed all that out, I will be looking at a lower time period chart to get an early entry with a tight stop. If I do take a trade on this, I will post the chart I am looking at. All TBD. This is my idea, if you like it, please make the trade your own and follow your own trading rules.
AMEX:XBILong
by jaxdog
Opening (IRA): XBI March 21st 86 Covered Call... for an 84.20 debit. Comments: Adding to my position at strikes better than what I currently have on, selling the -75 delta call against shares to emulate the delta metrics of a 25 delta short put, but with the built-in defense of the short call. Metrics: Buying Power Effect/Break Even: 84.20 Max Profit: 1.80 ROC at Max: 2.14% 50% Max: .90 ROC at 50% Max: 1.07% Will generally look to take profit at 50% max, add at intervals, assuming I can get in at strikes better than what I currently have on, and/or roll out the short call if my take profit isn't hit.
AMEX:XBILong
by NaughtyPines
Opening (IRA): XBI January 17th 92 Covered Call... for a 90.47 debit. Comments: IVR/IV isn't fantastic here at 11.1/26.3%, but there is some IV skew to take advantage of on the call side -- 31.34% at the 92 call relative to 26.62% at the 92 put. Selling the -75 delta call against shares to emulate the delta metrics of a 25 delta short put to take advantage of the IV skew and the built-in defense of the short call. From a charting standpoint, the break even sets up nicely with the "RFK, Jr. low" in November. Metrics: Buying Power Effect/Break Even: 90.47 Max Profit: 1.53 ROC at Max: 1.69% 50% Max: .77 ROC at 50% Max: .85
AMEX:XBILong
by NaughtyPines
Opening (IRA): XBI February 21st 85 Covered Call... for an 83.01 debit. Comments: Adding at strikes/break evens better than what I currently have on, selling the -75 delta call against shares to emulate the delta metrics of a 25 delta short put, but with the built-in defense of the short call. Metrics: Buying Power Effect/Break Even: 83.01/share Max Profit: 1.99 ROC at Max: 2.40% 50% Max: 1.00 ROC at 50% Max: 1.20% Will generally look to take profit at 50% max, roll out short call on take profit point test.
AMEX:XBILong
by NaughtyPines
Healthcare Sector Poised For A 7% to 15% Rally Into Early 2025My continued research to help traders shows the US Healthcare and Biotech sectors are poised for a very large rally phase into early 2025. Particularly, XLV and XBI seem uniquely setup to rally more than 9-10% over the next 60 to 90+ days. This video explains how I use my Adaptive Dynamic Learning Predictive Modeling system to find opportunities other people miss. Using technology, predictive modeling, and inference engines like this is one advantage I have because I can build any type of technology or system I like - and use it on any symbol or interval I like. Now is the time to prepare for the big moves headed into 2025. Follow my research if you want to target the biggest price swings in the markets. Get some. #trading #research #investing #tradingalgos #tradingsignals #cycles #fibonacci #elliotwave #modelingsystems #stocks #bitcoin #btcusd #cryptos #spy #es #nq #gold
AMEX:XLVLong
by BradMatheny
KRRO a biotech company with earnings coming LONGKRRO is in the biotechnology space in the gene-editing realm. It is in portfolios of C. Woods . A recent analyst gave it an upside to 100 which is very favorable given its product line and track record with an all-time high of about $250 ( which is about 450% over current valuation) On the one-hour time frame, it has had a great week and is breaking out over its moving averages as well as bullish momentum on the dual TF RSI indicator. This is a stock-long trade in the biotechnology sector which is prognosticated to be among the best of 2024. The dramatic reversal on the chart tells me this is a long entry. Targeting $57.5 in the short term and $75.00 for most of the position in consideration of the analyst report.
NASDAQ:KRROLong
by AwesomeAvani
3
XBI biotech ETF EW count optionsSharing an intermediate view of the EW count options for XBI. The short-term bullish range is $97-$98. The short-term bearish target ranges are $89 - $88.50 and $87. The bearish count, in red, drops the price to $81ish as first support. If, $81 range does not hold, $72 is the C wave target. In the meantime, I anticipate a lot of chop in the range from $86 - $100 in the next couple months until a rate cut occurs. As speculation of a rate cut increases, the price can begin to gravitate toward $104. When an interest rate cut is proposed, XBI will blast to the $140s but I am reserved about this outcome at this time.
AMEX:XBI
by MontBel
1
VTYX- a risky biotechnology penny stock LONGVTRX is on a 120 minute chart, currently trading at 90% off its ATH and 50% above its absolute long term support level. Price tried to cross above the long term mean VWAP 3 months ago but was rejected. I anticipate that in time it will try to so so again. From 3.3 to a target of 9 would be a move in the neighborhood of 300%. I will take a small position long trade here. This will be highly volatile. I will place a 25% stop loss to give VTRX room to roam for a couple of earnings periods. Once the price rises 25% I will convert to a trailing stop loss of 25% and make the then risk free trade low maintenance.
NASDAQ:VTYXLong
by AwesomeAvani
NVAX pushed to bottom of its channel LONGNVAX powered off its earnings and a news catalyst and is overdue now for a correction. While in an ascending channel NVAX is now at the bottom of the channel perhaps due to the general market moves this week. From here it can move up in the channel or breakdown and fall into a significant correction from the uptrend since May 10th. I am bullish on NVAX and have a prior perspective of an insider. I have realized profit six figures from my call options for January 2025 and have a large number remaining in the trade. At this juncture, I will watch for NVAX to move up in the channel and take a trade of shares and some call options for 15.00 expiring in June 2025 to take advantage of long term capital gains on the options. The FDA is currently reviewing some COVID vaccine data which is particularly relevant to NVAX. The volume profile has a shelf at 14.25 which will be my stop loss on the shares. The options will have a 20% stop loss. Considering the level from which NVAX has fallen over a period of some period there is great potential in my opinion.
NASDAQ:NVAXLong
by AwesomeAvani
2
Opening (IRA): XBI July 19th 83 Monied Covered Call... for an 80.91 debit. Comments: After taking off my August 88 monied for a small profit, re-upping in shorter duration, but with a better break even than what I had with the August 88. Selling the -75 delta call against a one lot of stock to emulate the delta metrics of a 25 delta short put, but with built-in short call defense. My general goal here is to not hang out in these positions for lengthy periods of time, but to take profit, re-evaluate the market for where the juice is at, and re-up if the underlying remains "sexy" from a premium-selling standpoint. XBI's 30-day IV isn't stellar at 30.9%, but it's toward the top of my IV screener, with miners and the silver ETF hogging three spots: TQQQ (51.8%); GDXJ (44.0%); GDX (38.7%); SLV (32.3%); SMH (31.6%); EWZ (31.1%); XBI (30.9%). Metrics: Buying Power Effect/Break Even: 80.91 Max Profit: 2.09 ROC at Max: 2.58% ROC at 50% Max: 1.29% Will generally look to take profit at 50% max and/or roll out the short call aspect if it reaches 50% max or there is a test of my downside break even.
AMEX:XBILong
by NaughtyPines
ZURA a med tech microcap with catalysts LONGZURA a penny stock has catalysts- an FDA action is soon upcoming and an insider bought a lot more shares. The 120-minute chart shows a solid trend up since earnings March 28th. This pre-revenue company beat earnings with less cash burn than expected. Another earnings report is about a month away. Price has settled to the support of the longest EMA line. I see an opportunity here for a long trade toward the earnings in a month. The longer black RSI line above the 50 level while the shorter green line shows the oversold undervalued condition for an entry.
NASDAQ:ZURALong
by AwesomeAvani
Opening (IRA): XBI June 21st 82 Short Put... for a 1.90 credit. Comments: Selling a put here, since the resulting cost basis if assigned shares would be lower than the cost basis of the position I've currently got on now. The full position is now a June 21st 82/88 covered strangle (i.e., short put, stock, short call). Will look to take profit at 50% max. Metrics: Buying Power Effect/Break Even/Cost Basis in Shares if Assigned: 80.10 ROC at Max as a Function of Buying Power Effect: 2.37% ROC at 50% Max as a Function of Buying Power Effect: 1.19% Delta/Theta: 23.36/2.42
AMEX:XBILong
by NaughtyPines